0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The complex architecture of p53 binding sites

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sequence-specific protein-DNA interactions are at the heart of the response of the tumor-suppressor p53 to numerous physiological and stress-related signals. Large variability has been previously reported in p53 binding to and transactivating from p53 response elements (REs) due, at least in part, to changes in direct (base) and indirect (shape) readouts of p53 REs. Here, we dissect p53 REs to decipher the mechanism by which p53 optimizes this highly regulated variable level of interaction with its DNA binding sites. We show that hemi-specific binding is more prevalent in p53 REs than previously envisioned. We reveal that sequences flanking the REs modulate p53 binding and activity and show that these effects extend to 4–5 bp from the REs. Moreover, we show here that the arrangement of p53 half-sites within its REs, relative to transcription direction, has been fine-tuned by selection pressure to optimize and regulate the response levels from p53 REs. This directionality in the REs arrangement is at least partly encoded in the structural properties of the REs. Furthermore, we show here that in the p21-5′ RE the orientation of the half-sites is such that the effect of the flanking sequences is minimized and we discuss its advantages.

          Related collections

          Most cited references96

          • Record: found
          • Abstract: found
          • Article: not found

          The first 30 years of p53: growing ever more complex.

          Thirty years ago p53 was discovered as a cellular partner of simian virus 40 large T-antigen, the oncoprotein of this tumour virus. The first decade of p53 research saw the cloning of p53 DNA and the realization that p53 is not an oncogene but a tumour suppressor that is very frequently mutated in human cancer. In the second decade of research, the function of p53 was uncovered: it is a transcription factor induced by stress, which can promote cell cycle arrest, apoptosis and senescence. In the third decade after its discovery new functions of this protein were revealed, including the regulation of metabolic pathways and cytokines that are required for embryo implantation. The fourth decade of research may see new p53-based drugs to treat cancer. What is next is anybody's guess.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Transcriptional control of human p53-regulated genes.

            The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Putting p53 in Context.

              TP53 is the most frequently mutated gene in human cancer. Functionally, p53 is activated by a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative transcriptional program that touches upon a bewildering array of biological responses. Despite the many unveiled facets of the p53 network, a clear appreciation of how and in what contexts p53 exerts its diverse effects remains unclear. How can we interpret p53's disparate activities and the consequences of its dysfunction to understand how cell type, mutation profile, and epigenetic cell state dictate outcomes, and how might we restore its tumor-suppressive activities in cancer?
                Bookmark

                Author and article information

                Contributors
                Journal
                Nucleic Acids Res
                Nucleic Acids Res
                nar
                Nucleic Acids Research
                Oxford University Press
                0305-1048
                1362-4962
                22 February 2021
                14 January 2021
                14 January 2021
                : 49
                : 3
                : 1364-1382
                Affiliations
                Department of Biology, Technion - Israel Institute of Technology , Technion City, Haifa 3200003, Israel
                Department of Biology, Technion - Israel Institute of Technology , Technion City, Haifa 3200003, Israel
                Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento , via Sommarive 9, 38123 Trento, TN, Italy
                Department of Biology, Technion - Israel Institute of Technology , Technion City, Haifa 3200003, Israel
                Department of Biology, Technion - Israel Institute of Technology , Technion City, Haifa 3200003, Israel
                Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento , via Sommarive 9, 38123 Trento, TN, Italy
                Department of Biology, Technion - Israel Institute of Technology , Technion City, Haifa 3200003, Israel
                Author notes
                To whom correspondence should be addressed. Tel: +972 4 8293767; Fax: +972 4 8225153; Email: bitali@ 123456technion.ac.il
                Author information
                https://orcid.org/0000-0002-8767-1637
                https://orcid.org/0000-0002-9700-3392
                Article
                gkaa1283
                10.1093/nar/gkaa1283
                7897521
                33444431
                f1bccecd-ef3f-4723-9f35-a021fb83edaf
                © The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 24 December 2020
                : 22 December 2020
                : 05 August 2020
                Page count
                Pages: 19
                Funding
                Funded by: Israel Science Foundation, DOI 10.13039/501100003977;
                Award ID: 1517/14
                Funded by: Italian Association for Cancer Research, DOI 10.13039/501100005010;
                Award ID: IG #18985
                Categories
                AcademicSubjects/SCI00010
                Gene regulation, Chromatin and Epigenetics

                Genetics
                Genetics

                Comments

                Comment on this article